PatientsVille.com Logo

Cisplatin Side Effects

PatientsVille

Common Cisplatin Side Effects


The most commonly reported Cisplatin side effects (click to view or check a box to report):

Dehydration (1057)
Nausea (901)
Vomiting (789)
Neutropenia (592)
Diarrhoea (569)
Febrile Neutropenia (530)
Pyrexia (429)
Anaemia (395)
Renal Failure Acute (356)
Mucosal Inflammation (339)
Asthenia (317)
Fatigue (306)
Dyspnoea (297)
Pulmonary Embolism (290)
Thrombocytopenia (289)
Haemoglobin Decreased (285)
Pneumonia (284)
Dysphagia (281)
Hypotension (254)
White Blood Cell Count Decreased (230)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Cisplatin Side Effects Reported to FDA



Cisplatin Side Effect Report#9999636
Pancytopenia
This is a report of a 71-year-old male patient (weight: NA) from HU, suffering from the following health symptoms/conditions: small cell lung cancer, who was treated with Cisplatin (dosage: 03dec13-03dec13?06jan14-06jan14, start time: 2012), combined with:
  • Etoposide (03dec13-05dec13?06jan14-08jan14)
  • Irbesartan
and developed a serious reaction and side effect(s): Pancytopenia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatin treatment in male patients, resulting in Pancytopenia side effect. The patient was hospitalized.
Cisplatin Side Effect Report#9999338
Second Primary Malignancy, Acute Biphenotypic Leukaemia, Off Label Use
This report suggests a potential Cisplatin Second Primary Malignancy side effect(s) that can have serious consequences. A 46-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: endometrial cancer and used Cisplatin (dosage: NA) starting NS. After starting Cisplatin the patient began experiencing various side effects, including: Second Primary Malignancy, Acute Biphenotypic Leukaemia, Off Label UseAdditional drugs used concurrently:
  • Irinotecan
  • Paclitaxel
  • Carboplatin
  • Docetaxel
Although Cisplatin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Second Primary Malignancy, may still occur.
Cisplatin Side Effect Report#9995331
Anaemia, Epistaxis, Petechiae, Thrombocytopenia, Off Label Use
This Anaemia problem was reported by a physician from IT. A 71-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: pleural mesothelioma malignant. On
May 22, 2013 this consumer started treatment with Cisplatin (dosage: 1 Dosage Forms Daily;). The following drugs were being taken at the same time:
  • Alimta - Eli Lilly Nederland Bv (1 Dosage Forms Daily;)
  • Gastrogel
  • Pantorc
When using Cisplatin, the patient experienced the following unwanted symptoms/side effects: Anaemia, Epistaxis, Petechiae, Thrombocytopenia, Off Label UseThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Anaemia, may become evident only after a product is in use by the general population.
Cisplatin Side Effect Report#9993435
Pancytopenia
This Pancytopenia side effect was reported by a health professional from CZ. A 70-year-old female patient (weight:NA) experienced the following symptoms/conditions: neuroendocrine carcinoma of the skin.The patient was prescribed Cisplatin (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Etoposide
.After starting to take Cisplatin the consumer reported adverse symptoms, such as: PancytopeniaThese side effects may potentially be related to Cisplatin.
Cisplatin Side Effect Report#9991710
Bone Marrow Failure, Circulatory Collapse
This is a report of a 55-year-old female patient (weight: NA) from IT, suffering from the following health symptoms/conditions: lung neoplasm malignant, who was treated with Cisplatino Teva Italia (dosage: 70 Milligram Daily; Cycle 1, start time:
Nov 30, 2013), combined with: NA. and developed a serious reaction and side effect(s): Bone Marrow Failure, Circulatory Collapse after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatino Teva Italia treatment in female patients, resulting in Bone Marrow Failure side effect.
Cisplatin Side Effect Report#9989940
Second Primary Malignancy, Acute Biphenotypic Leukaemia
This report suggests a potential Cisplatin Second Primary Malignancy side effect(s) that can have serious consequences. A 46-year-old female patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: endometrial cancer and used Cisplatin (dosage: Daily Dose:558 Mg/body) starting NS. After starting Cisplatin the patient began experiencing various side effects, including: Second Primary Malignancy, Acute Biphenotypic LeukaemiaAdditional drugs used concurrently:
  • Irinotecan
  • Paclitaxel (2487 Mg/body (cumulative Dose))
  • Carboplatin (11700 Mg/body(cumulative Dose))
  • Docetaxel
Although Cisplatin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Second Primary Malignancy, may still occur.
Cisplatin Side Effect Report#9989176
Febrile Neutropenia, Diarrhoea, Nausea
This Febrile Neutropenia problem was reported by a consumer or non-health professional from US. A 71-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: gastric cancer. On NS this consumer started treatment with Cisplatin (dosage: NA). The following drugs were being taken at the same time:
  • Irinotecan
When using Cisplatin, the patient experienced the following unwanted symptoms/side effects: Febrile Neutropenia, Diarrhoea, NauseaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Febrile Neutropenia, may become evident only after a product is in use by the general population.
Cisplatin Side Effect Report#9989175
Castleman^s Disease, Off Label Use, Disease Progression
This Castleman^s Disease side effect was reported by a consumer or non-health professional from US. A 65-year-old male patient (weight:NA) experienced the following symptoms/conditions: castleman^s disease.The patient was prescribed Cisplatin (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Cytarabine
  • Dexamethasone
  • Doxorubicin
  • Prednisone
  • Cyclophosphamide
  • Rituximab
  • Vincristine
.After starting to take Cisplatin the consumer reported adverse symptoms, such as: Castleman^s Disease, Off Label Use, Disease ProgressionThese side effects may potentially be related to Cisplatin.
Cisplatin Side Effect Report#9988804
Rash, Capillary Leak Syndrome, Swelling Face, Local Swelling, Vomiting, Nausea
This is a report of a 60-year-old female patient (weight: NA) from GB, suffering from the following health symptoms/conditions: NA, who was treated with Cisplatin (dosage: NA, start time:
Dec 03, 2013), combined with:
  • Alimta
and developed a serious reaction and side effect(s): Rash, Capillary Leak Syndrome, Swelling Face, Local Swelling, Vomiting, Nausea after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatin treatment in female patients, resulting in Rash side effect. The patient was hospitalized.
Cisplatin Side Effect Report#9988701
Anaemia, Epistaxis, Petechiae, Thrombocytopenia, Off Label Use
This report suggests a potential Cisplatin Anaemia side effect(s) that can have serious consequences. A 71-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: pleural mesothelioma malignant and used Cisplatin (dosage: NA) starting
May 22, 2013. After starting Cisplatin the patient began experiencing various side effects, including: Anaemia, Epistaxis, Petechiae, Thrombocytopenia, Off Label UseAdditional drugs used concurrently:
  • Alimta
  • Aluminium Hydroxide Gel
  • Magnesium Hydroxide
  • Magnesium Trisilicate
  • Pantorc
The patient was hospitalized. Although Cisplatin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Anaemia, may still occur.
Cisplatin Side Effect Report#9982376
Nausea, Weight Decreased, Fear, Vomiting, Failure To Thrive, Dehydration
This Nausea problem was reported by a consumer or non-health professional from Country Not Specified. A 61-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Cisplatin (dosage: NA). The following drugs were being taken at the same time:
  • Fentanyl Patch
  • Oxycodone
  • Oxycontin
When using Cisplatin, the patient experienced the following unwanted symptoms/side effects: Nausea, Weight Decreased, Fear, Vomiting, Failure To Thrive, DehydrationAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Nausea, may become evident only after a product is in use by the general population.
Cisplatin Side Effect Report#9980711
Constipation
This Constipation side effect was reported by a consumer or non-health professional from US. A 77-year-old female patient (weight:NA) experienced the following symptoms/conditions: lung neoplasm malignant.The patient was prescribed Cisplatin (drug dosage: NA), which was initiated on
Sep 11, 2013. Concurrently used drugs:
  • Gemcitabine
.After starting to take Cisplatin the consumer reported adverse symptoms, such as: ConstipationThese side effects may potentially be related to Cisplatin.
Cisplatin Side Effect Report#9980687
Trousseau^s Syndrome, Intracranial Venous Sinus Thrombosis, Cerebral Haemorrhage, Hemiplegia, Headache, Vomiting
This is a report of a 43-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: gastric cancer stage iv, who was treated with Cisplatin (dosage: NA, start time: NS), combined with:
  • Gimeracil
  • Oteracil Potassium
  • Tegafur
and developed a serious reaction and side effect(s): Trousseau^s Syndrome, Intracranial Venous Sinus Thrombosis, Cerebral Haemorrhage, Hemiplegia, Headache, Vomiting after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatin treatment in female patients, resulting in Trousseau^s Syndrome side effect.
Cisplatin Side Effect Report#9980644
Trousseau^s Syndrome, Balance Disorder, Dizziness, Cerebellar Ataxia, Nystagmus, Viith Nerve Paralysis, Cerebral Infarction
This report suggests a potential Cisplatin Trousseau^s Syndrome side effect(s) that can have serious consequences. A 67-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: gastric cancer stage iii and used Cisplatin (dosage: NA) starting NS. After starting Cisplatin the patient began experiencing various side effects, including: Trousseau^s Syndrome, Balance Disorder, Dizziness, Cerebellar Ataxia, Nystagmus, Viith Nerve Paralysis, Cerebral InfarctionAdditional drugs used concurrently:
  • Gimeracil
  • Oteracil Potassium
  • Tegafur
Although Cisplatin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Trousseau^s Syndrome, may still occur.
Cisplatin Side Effect Report#9980473
Second Primary Malignancy, Myelodysplastic Syndrome, Fatigue
This Second Primary Malignancy problem was reported by a consumer or non-health professional from US. A 44-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: malignant melanoma. On NS this consumer started treatment with Cisplatin (dosage: NA). The following drugs were being taken at the same time:
  • Dacarbazine
  • Dacarbazine
  • Nimustine Hydrochloride
  • Nimustine Hydrochloride
  • Vincristine
When using Cisplatin, the patient experienced the following unwanted symptoms/side effects: Second Primary Malignancy, Myelodysplastic Syndrome, FatigueAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Second Primary Malignancy, may become evident only after a product is in use by the general population.
Cisplatin Side Effect Report#9973357
Blood Pressure Increased, Aortic Dissection, Carotid Artery Dissection, Peripheral Artery Dissection, Pleural Effusion, Atelectasis
This Blood Pressure Increased side effect was reported by a physician from US. A 44-year-old male patient (weight:NA) experienced the following symptoms/conditions: pancreatic carcinoma metastatic.The patient was prescribed Cisplatin (drug dosage: On D1, 15 Of 4-w Cycle), which was initiated on NS. Concurrently used drugs:
  • Gemcitabine (On D1, 8, 15 Of 4-w Cycle)
.After starting to take Cisplatin the consumer reported adverse symptoms, such as: Blood Pressure Increased, Aortic Dissection, Carotid Artery Dissection, Peripheral Artery Dissection, Pleural Effusion, AtelectasisThese side effects may potentially be related to Cisplatin. The patient was hospitalized.
Cisplatin Side Effect Report#9972856
Second Primary Malignancy, Acute Myeloid Leukaemia, Myelodysplastic Syndrome
This is a report of a 65-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: cervix carcinoma, who was treated with Cisplatin (dosage: 504 Mg/body Cumulative Dose, start time: NS), combined with:
  • Paclitaxel (2106 Mg/body Cumulative Dose)
  • Etoposide
  • Carboplatin (3340 Mg/body Cumulative Dose)
  • Docetaxel
  • Ifosfamide
  • Nedaplatin
  • Fluorouracil
and developed a serious reaction and side effect(s): Second Primary Malignancy, Acute Myeloid Leukaemia, Myelodysplastic Syndrome after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatin treatment in female patients, resulting in Second Primary Malignancy side effect.
Cisplatin Side Effect Report#9972314
Tuberculous Pleurisy
This report suggests a potential Cisplatin Tuberculous Pleurisy side effect(s) that can have serious consequences. A 38-year-old male patient (weight: NA) from IN was diagnosed with the following symptoms/conditions: NA and used Cisplatin (dosage: NA) starting NS. After starting Cisplatin the patient began experiencing various side effects, including: Tuberculous PleurisyAdditional drugs used concurrently: NA. Although Cisplatin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Tuberculous Pleurisy, may still occur.
Cisplatin Side Effect Report#9971444
Sinus Bradycardia, Cholecystitis, Hypokalaemia, Hypomagnesaemia
This Sinus Bradycardia problem was reported by a health professional from US. A 29-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hodgkin^s disease. On NS this consumer started treatment with Cisplatin (dosage: NA). The following drugs were being taken at the same time:
  • Etoposide (etoposide)
  • Methylprednisolone (methylpredisolone)
  • Cytarabine (cytarabine)
When using Cisplatin, the patient experienced the following unwanted symptoms/side effects: Sinus Bradycardia, Cholecystitis, Hypokalaemia, HypomagnesaemiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Sinus Bradycardia, may become evident only after a product is in use by the general population.
Cisplatin Side Effect Report#9970018
Second Primary Malignancy, Acute Myeloid Leukaemia
This Second Primary Malignancy side effect was reported by a physician from JP. A 72-year-old female patient (weight:NA) experienced the following symptoms/conditions: cervix carcinoma.The patient was prescribed Cisplatin (drug dosage: Cumulative Dose:963mg/body), which was initiated on NS. Concurrently used drugs:
  • Paclitaxel (2400 Mg/body (cumulative Dose))
  • Carboplatin (5900 Mg/body(cumulative Dose))
  • Camptothecin (Comulative Doses-700mg/body)
.After starting to take Cisplatin the consumer reported adverse symptoms, such as: Second Primary Malignancy, Acute Myeloid LeukaemiaThese side effects may potentially be related to Cisplatin.
Cisplatin Side Effect Report#9961250
Oesophageal Ulcer Haemorrhage, Pneumonia Aspiration, Disease Recurrence, Gastric Cancer, Febrile Neutropenia, Diarrhoea, Nausea
This is a report of a 71-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: gastric cancer, who was treated with Cisplatin (dosage: 80 Mg/m2, Over 2 Hours On Day 1, start time: NS), combined with:
  • Irinotecan Hcl (60 Mg/m2 On Day 1 And 15)
and developed a serious reaction and side effect(s): Oesophageal Ulcer Haemorrhage, Pneumonia Aspiration, Disease Recurrence, Gastric Cancer, Febrile Neutropenia, Diarrhoea, Nausea after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatin treatment in female patients, resulting in Oesophageal Ulcer Haemorrhage side effect.
Cisplatin Side Effect Report#9960857
Herpes Dermatitis, Bacterial Test Positive
This report suggests a potential Cisplatin Inj. 50mg/50ml -bedford Labs, Inc Herpes Dermatitis side effect(s) that can have serious consequences. A 35-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Cisplatin Inj. 50mg/50ml -bedford Labs, Inc (dosage: NA) starting NS. After starting Cisplatin Inj. 50mg/50ml -bedford Labs, Inc the patient began experiencing various side effects, including: Herpes Dermatitis, Bacterial Test PositiveAdditional drugs used concurrently:
  • Bleomycin
The patient was hospitalized. Although Cisplatin Inj. 50mg/50ml -bedford Labs, Inc demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Herpes Dermatitis, may still occur.
Cisplatin Side Effect Report#9959744
Viith Nerve Paralysis, Hemiparesis, Ischaemic Stroke
This Viith Nerve Paralysis problem was reported by a physician from US. A 71-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: lung neoplasm malignant. On
Feb 03, 2014 this consumer started treatment with Cisplatin (dosage: NA). The following drugs were being taken at the same time:
  • Pemetrexed
  • Panobinostat
When using Cisplatin, the patient experienced the following unwanted symptoms/side effects: Viith Nerve Paralysis, Hemiparesis, Ischaemic StrokeThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Viith Nerve Paralysis, may become evident only after a product is in use by the general population.
Cisplatin Side Effect Report#9958653
Oesophageal Fistula, Purulent Pericarditis, Hypotension, Cardiac Tamponade, Streptococcus Test Positive, Oesophageal Stenosis, Oesophageal Squamous Cell Carcinoma Recurrent, Oesophageal Squamous Cell Carcinoma, Condition Aggravated
This Oesophageal Fistula side effect was reported by a physician from US. A 56-year-old female patient (weight:NA) experienced the following symptoms/conditions: squamous cell carcinoma.The patient was prescribed Cisplatin (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Cisplatin the consumer reported adverse symptoms, such as: Oesophageal Fistula, Purulent Pericarditis, Hypotension, Cardiac Tamponade, Streptococcus Test Positive, Oesophageal Stenosis, Oesophageal Squamous Cell Carcinoma Recurrent, Oesophageal Squamous Cell Carcinoma, Condition AggravatedThese side effects may potentially be related to Cisplatin. The patient was hospitalized.
Cisplatin Side Effect Report#9958544
Sinus Bradycardia, Cholecystitis, Abdominal Pain, Nausea, Vomiting, Hypokalaemia, Hypomagnesaemia
This is a report of a 29-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: hodgkin^s disease, who was treated with Cisplatin (dosage: NA, start time: NS), combined with:
  • Etoposide
  • Methylprednisolone
  • Cytarabine
and developed a serious reaction and side effect(s): Sinus Bradycardia, Cholecystitis, Abdominal Pain, Nausea, Vomiting, Hypokalaemia, Hypomagnesaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cisplatin treatment in female patients, resulting in Sinus Bradycardia side effect. The patient was hospitalized.


1 of 297 


The appearance of Cisplatin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Cisplatin Side Effects for Women?

Women Side EffectsReports
Nausea 415
Dehydration 403
Vomiting 394
Neutropenia 262
Diarrhoea 242
Febrile Neutropenia 205
Anaemia 182
Haemoglobin Decreased 159
Pyrexia 149
Asthenia 136

What are common Cisplatin Side Effects for Men?

Men Side EffectsReports
Dehydration 652
Nausea 479
Vomiting 391
Diarrhoea 326
Neutropenia 323
Febrile Neutropenia 320
Pyrexia 279
Renal Failure Acute 257
Mucosal Inflammation 241
Pneumonia 219

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Cisplatin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Cisplatin Side Effects

    Did You Have a Cisplatin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Cisplatin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Cisplatin Safety Alerts, Active Ingredients, Usage Information

    NDC0069-0081
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameCisplatin
    NameCisplatin
    Dosage FormINJECTION
    RouteINTRAVENOUS
    On market since20120419
    LabelerPfizer Laboratories Div Pfizer Inc.
    Active Ingredient(s)CISPLATIN
    Strength(s)1
    Unit(s)mg/mL
    Pharma ClassPlatinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]

    More About Cisplatin

    Side Effects reported to FDA: 7424

    Cisplatin safety alerts: No

    Reported deaths: 1422

    Reported hospitalizations: 5393

    Latest Cisplatin clinical trials